We are live on ! Find out more
TXG icon

10x Genomics
TXG

314 hedge funds and large institutions have $6.29B invested in 10x Genomics in 2022 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 135 increasing their positions, 72 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 72

1.43% more ownership

Funds ownership: 87.32% → 88.75% (+1.4%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

14% less funds holding

Funds holding: 365 → 314 (-51)

35% less call options, than puts

Call options by funds: $20.5M | Put options by funds: $31.7M

47% less capital invested

Capital invested by funds: $11.9B → $6.29B (-$5.58B)

48% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 96

Holders
314
Holders Change
-51
Holders Change %
-13.97%
% of All Funds
4.95%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
50
Increased
135
Reduced
72
Closed
96
Calls
$20.5M
Puts
$31.7M
Net Calls
-$11.2M
Net Calls Change
-$3.96M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$389M
2
Sands Capital Management
Sands Capital Management
Virginia
+$134M
3
BlackRock
BlackRock
New York
+$99.6M
4
AIM
ARK Investment Management
Florida
+$63.9M
5
1WCM
12 West Capital Management
New York
+$45M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$268M
2
DCP
D1 Capital Partners
New York
-$239M
3
William Blair Investment Management
William Blair Investment Management
Illinois
-$159M
4
JCM
JS Capital Management
New York
-$80.5M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$68.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
276
Lindbrook Capital
California
$3K -$3.5K -40 -53%
DFCM
277
Dark Forest Capital Management
Puerto Rico
$3K -$3.15K -36 -49%
AWM
278
Activest Wealth Management
Florida
$3K – – –
MAM
279
Meeder Asset Management
Ohio
$3K +$3.24K +37 New
ADL
280
Asset Dedication LLC
California
$2K – – –
GI
281
Gradient Investments
Minnesota
$2K – – –
GWS
282
Glassman Wealth Services
Virginia
$2K +$700 +8 +35%
Loomis, Sayles & Company
283
Loomis, Sayles & Company
Massachusetts
$2K +$1.84K +21 New
Federated Hermes
284
Federated Hermes
Pennsylvania
$2K +$2.8K +32 New
T
285
TCWP
Ohio
$2K +$3.41K +39 New
BWL
286
Bogart Wealth LLC
Virginia
$1K – – –
CA
287
Clearstead Advisors
Ohio
$1K – – –
PWMG
288
Prestige Wealth Management Group
New Jersey
$1K – – –
RA
289
Rise Advisors
New York
$1K – – –
SCA
290
Stonebridge Capital Advisors
Minnesota
$1K – – –
SWM
291
Sugarloaf Wealth Management
Georgia
$1K – – –
TWA
292
TCI Wealth Advisors
Arizona
$1K – – –
TFA
293
Toth Financial Advisory
Virginia
$1K – – –
JWA
294
JFS Wealth Advisors
Pennsylvania
$1K +$437 +5 +125%
SPIA
295
Steward Partners Investment Advisory
New York
$1K +$700 +8 New
TFO
296
Tarbox Family Office
California
$1K +$700 +8 +73%
PGAM
297
Princeton Global Asset Management
New Jersey
$1K +$787 +9 New
CMBA
298
C.M. Bidwell & Associates
Hawaii
$1K +$1.05K +12 New
AF
299
Advisornet Financial
Minnesota
$1K +$1.31K +15 New
DCP
300
D1 Capital Partners
New York
– -$239M -1,605,000 Closed
10 11
12
13 14

TXG Hedge Fund Activity: Q1 2022 in Review

314 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q1 2022, worth a combined $6.29B — down 47% from $11.9B a quarter earlier.

Sellers outnumbered buyers: 96 funds closed out of TXG and 50 opened new positions — a net loss of 46 holders — while 72 trimmed existing stakes and 135 added.

The largest buyer was Morgan Stanley, adding an estimated $389M. The largest seller was Fidelity Investments, cutting an estimated $268M.

  • 314 institutional investors held 10x Genomics (TXG) as of Q1 2022, down from 365 in Q4 2021.
  • Funds reported $6.29B of 10x Genomics stock for Q1 2022, down 47% quarter-over-quarter.
  • 50 funds opened new 10x Genomics positions in Q1 2022 and 96 closed out, a net change of -46 holders.
  • The largest 10x Genomics buyer in Q1 2022 was Morgan Stanley, an estimated $389M added.
  • The largest 10x Genomics seller in Q1 2022 was Fidelity Investments, an estimated $268M sold.

Based on aggregated 13F filings for Q1 2022.